Sigbrit Forsman

Title: Sigbrit Forsman: Innovator in Thromboembolism Treatment

Introduction

Sigbrit Forsman is a notable inventor based in Lerum, Sweden. She has made significant contributions to the field of medicine, particularly in the development of treatments for thromboembolism. With a total of 2 patents, her work is recognized for its innovative approach to drug formulation.

Latest Patents

Forsman's latest patents include a method for prophylaxis and/or treatment of thromboembolism. This involves a new oral immediate release (IR) formulation in solid form for a low molecular weight thrombin inhibitor. The formulation is characterized by pH-dependent dissolution and comprises a filler or a combination of fillers with disintegrant properties in an amount higher than 35% w/w of the formulation. Another patent focuses on an immediate release tablet with similar characteristics, emphasizing the importance of effective drug delivery systems in medical treatments.

Career Highlights

Forsman is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. Her work at AstraZeneca has allowed her to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

She has collaborated with notable colleagues, including Christer Karlsson and Magnus Karlsson, to advance her research and innovations in the field.

Conclusion

Sigbrit Forsman's contributions to thromboembolism treatment through her innovative patents highlight her role as a key figure in medical research. Her work continues to influence the development of effective therapeutic solutions.